ISU Abxis Co., Ltd.

KOSDAQ:A086890 Stock Report

Market Cap: ₩160.8b

ISU Abxis Past Earnings Performance

Past criteria checks 0/6

ISU Abxis has been growing earnings at an average annual rate of 37.8%, while the Biotechs industry saw earnings growing at 3.8% annually. Revenues have been growing at an average rate of 24.3% per year.

Key information

37.8%

Earnings growth rate

42.9%

EPS growth rate

Biotechs Industry Growth11.7%
Revenue growth rate24.3%
Return on equity-6.9%
Net Margin-9.0%
Last Earnings Update30 Sep 2024

Recent past performance updates

Recent updates

Why Investors Shouldn't Be Surprised By ISU Abxis Co., Ltd.'s (KOSDAQ:086890) 26% Share Price Plunge

Nov 14
Why Investors Shouldn't Be Surprised By ISU Abxis Co., Ltd.'s (KOSDAQ:086890) 26% Share Price Plunge

ISU Abxis (KOSDAQ:086890) Takes On Some Risk With Its Use Of Debt

Nov 12
ISU Abxis (KOSDAQ:086890) Takes On Some Risk With Its Use Of Debt

ISU Abxis Co., Ltd.'s (KOSDAQ:086890) Intrinsic Value Is Potentially 84% Above Its Share Price

Aug 07
ISU Abxis Co., Ltd.'s (KOSDAQ:086890) Intrinsic Value Is Potentially 84% Above Its Share Price

ISU Abxis (KOSDAQ:086890) Takes On Some Risk With Its Use Of Debt

Jun 10
ISU Abxis (KOSDAQ:086890) Takes On Some Risk With Its Use Of Debt

Benign Growth For ISU Abxis Co., Ltd. (KOSDAQ:086890) Underpins Its Share Price

Mar 12
Benign Growth For ISU Abxis Co., Ltd. (KOSDAQ:086890) Underpins Its Share Price

We Think ISU Abxis (KOSDAQ:086890) Has A Fair Chunk Of Debt

Feb 17
We Think ISU Abxis (KOSDAQ:086890) Has A Fair Chunk Of Debt

ISU Abxis'(KOSDAQ:086890) Share Price Is Down 21% Over The Past Three Years.

Dec 25
ISU Abxis'(KOSDAQ:086890) Share Price Is Down 21% Over The Past Three Years.

Revenue & Expenses Breakdown

How ISU Abxis makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

KOSDAQ:A086890 Revenue, expenses and earnings (KRW Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Sep 2456,176-5,04615,13010,954
30 Jun 2462,054-5,97015,97511,919
31 Mar 2464,057-8,08917,29813,871
31 Dec 2354,3063,61114,48315,210
30 Sep 2346,883-3,29214,96617,466
30 Jun 2348,237-4,73415,55117,104
31 Mar 2342,317-6,58213,74815,728
31 Dec 2241,170-7,24713,74413,368
30 Sep 2239,64930712,3939,164
30 Jun 2232,233-1,76611,1038,494
31 Mar 2229,324-69610,8307,630
31 Dec 2128,01883010,5977,568
30 Sep 2129,456-16,9338,23912,079
30 Jun 2127,184-16,14910,06410,037
31 Mar 2125,985-19,1259,77211,545
31 Dec 2025,607-19,86510,19112,650
30 Sep 2022,931-18,82211,75811,411
30 Jun 2021,437-20,0738,94713,965
31 Mar 2021,151-18,9379,34612,771
31 Dec 1921,019-17,8169,12512,595
30 Sep 1920,217-14,0889,56810,733
30 Jun 1920,034-12,1179,29410,784
31 Mar 1918,094-13,5079,33710,933
31 Dec 1816,746-12,9899,19910,099
30 Sep 1815,375-12,8258,68110,687
30 Jun 1816,239-12,2788,8059,939
31 Mar 1818,159-9,4807,8059,978
31 Dec 1719,459-8,7297,6259,885
30 Sep 1719,373-8,1027,07710,518
30 Jun 1719,943-6,9476,85710,243
31 Mar 1719,687-5,3846,8118,601
31 Dec 1619,055-4,3676,4047,673
30 Sep 1619,096-2,9186,3815,338
30 Jun 1615,694-6,9775,7724,956
31 Mar 1612,506-9,1615,3285,294
31 Dec 1511,471-9,7735,2575,340
30 Sep 158,901-9,9784,8584,649
30 Jun 158,211-8,2944,8724,534
31 Mar 157,529-10,7185,0234,254
31 Dec 147,097-11,1985,1514,293
30 Sep 147,893-10,4125,2033,881
30 Jun 147,727-10,5765,3554,426
31 Mar 148,746-7,6075,6454,278
31 Dec 138,164-8,1916,0704,202

Quality Earnings: A086890 is currently unprofitable.

Growing Profit Margin: A086890 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: A086890 is unprofitable, but has reduced losses over the past 5 years at a rate of 37.8% per year.

Accelerating Growth: Unable to compare A086890's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: A086890 is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (7.9%).

Return on Equity

High ROE: A086890 has a negative Return on Equity (-6.91%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/26 10:55
End of Day Share Price 2024/12/26 00:00
Earnings2024/09/30
Annual Earnings2023/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

ISU Abxis Co., Ltd. is covered by 6 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Song-hyup HanDaishin Securities Co. Ltd.
Byung Hwa HanEugene Investment & Securities Co Ltd.
Jung-In LeeKorea Investment & Securities Co., Ltd.